Evidence map›Paper›PMID 21740924›Full record

ArticlePharmacology, biochemistry, and behavior2011

Fatty acid amide hydrolase blockade attenuates the development of collagen-induced arthritis and related thermal hyperalgesia in mice.

Steven G Kinsey, Pattipati S Naidu, Benjamin F Cravatt, David T Dudley, Aron H Lichtman

Open access · greenAbstract read
In one paragraph

Article in Pharmacology, biochemistry, and behavior, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
5.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 84 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Study on the Mechanisms of Glrα3 in Pain Sensitization of Endometriosis.International journal of molecular sciences · 2024
    Article
  8. Review
  9. Cannabinoids in the Modulation of Oxidative Signaling.International journal of molecular sciences · 2023
    Review
  10. Impact of ΔBiomedicines · 2022
    Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

Steven G KinseyDepartment of Psychology, West Virginia University, Morgantown, WV 26506, USA. steven.kinsey@mail.wvu.edu
Pattipati S Naidu
Benjamin F Cravatt
David T Dudley
Aron H Lichtman
Virginia Commonwealth University · USPfizer (United States) · USScripps Research Institute · USWest Virginia University Hospitals · US

Funding

TRAINING IN THE PHARMACOLOGY OF ABUSED DRUGST32DA007027 · NIDA · VIRGINIA COMMONWEALTH UNIVERSITY · PI William L. Dewey · 1985 to 2026
$14.7M
THE ROLE OF ENDOGENOUS OPIOIDS IN SUDDEN INFANT DEATHP50DA005274 · NIDA · VIRGINIA COMMONWEALTH UNIVERSITY · PI DELORENZO, ROBERT JOHN · 1988 to 2011
$12.6M
SYNTHESIS OF SR141716A AND ANANDAMIDE ANALOGSP01DA009789 · NIDA · VIRGINIA COMMONWEALTH UNIVERSITY · PI LICHTMAN, ARON H · 1995 to 2013
$11.6M
STRUCTURAL STUDIES OF FAAHP01DA017259 · NIDA · SCRIPPS RESEARCH INSTITUTE, THE · PI CRAVATT, BENJAMIN F · 2004 to 2013
$10.6M
Enzymes That Regulate Fatty Acid Amide Function In VivoR01DA015197 · NIDA · SCRIPPS RESEARCH INSTITUTE, THE · PI CRAVATT, BENJAMIN F · 2002 to 2009
$2.5M
NIDA NIH HHS P01 DA009789NIDA NIH HHS P01DA009789NIDA NIH HHS P01 DA017259NIDA NIH HHS P01DA017259NIDA NIH HHS P50 DA005274NIDA NIH HHS P50DA005274NIDA NIH HHS R01 DA015197NIDA NIH HHS R01DA15197NIDA NIH HHS T32 DA007027NIDA NIH HHS T32DA007027
6 · The paper itself

Abstract

Fatty acid amide hydrolase (FAAH) is the primary degradative enzyme of the endocannabinoid anandamide (N-arachidonoylethanolamine), which activates cannabinoid CB(1) and CB(2) receptors. FAAH disruption reduces nociception in a variety of acute rodent models of inflammatory pain. The present study investigated whether these actions extend to the chronic, collagen-induced arthritis (CIA) model. We investigated the anti-arthritic and anti-hyperalgesic effects of genetic deletion or pharmacological inhibition of FAAH in the CIA model. FAAH (-/-) mice, and FAAH-NS mice that express FAAH exclusively in nervous tissue, displayed decreased severity of CIA and associated hyperalgesia. These phenotypic anti-arthritic effects were prevented by repeated daily injections of the CB(2) receptor antagonist, SR144528, but not the CB(1) receptor antagonist rimonabant. Similarly, repeated administration of the FAAH inhibitor URB597 reduced CIA severity, and acute administration of rimonabant, but not SR144528, blocked the anti-hyperalgesic effects of prolonged FAAH inhibition, suggesting that prolonged CB(2) receptor activation reduces the severity of CIA, whereas acute CB(1) receptor activation reduces CIA-induced hyperalgesia. In contrast, acute administration of URB597 elicited a CB(1) receptor-dependent anti-hyperalgesic effect. The observed anti-arthritic and anti-hyperalgesic properties of FAAH inhibition, coupled with a lack of apparent behavioral alterations, suggest that endocannabinoid modulating enzymes offer a promising therapeutic target for the development of novel pharmacological approaches to treat rheumatoid arthritis and associated hyperalgesia.

Indexed as

Hot TemperatureAmidohydrolasesAnimalsArthritis, ExperimentalBenzamidesCamphanesCarbamatesFatty Acid Amide HydrolasesFootGenotypeHyperalgesiaMaleMiceMice, Inbred DBAMice, KnockoutPain MeasurementAmidohydrolasesBenzamidesCamphanesCarbamatescyclohexyl carbamic acid 3'-carbamoylbiphenyl-3-yl esterFatty Acid Amide HydrolasesPyrazolesReceptor, Cannabinoid, CB1Receptor, Cannabinoid, CB2SR 144528

Identifiers

PMID21740924
PMCPMC3164582
OpenAlexW2066159223

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.